Christina A. Penfield MD, MPH , Megan C. Oakes MD, MSCI , Deysi Caballero RN , Lindsay N. Marty MD , Dana S. Berger MD , Michael P. Nageotte MD , Jennifer A. Mcnulty MD
{"title":"A randomized trial of postpartum ibuprofen in severe hypertensive disorders of pregnancy","authors":"Christina A. Penfield MD, MPH , Megan C. Oakes MD, MSCI , Deysi Caballero RN , Lindsay N. Marty MD , Dana S. Berger MD , Michael P. Nageotte MD , Jennifer A. Mcnulty MD","doi":"10.1016/j.ajog.2025.02.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Ibuprofen has been shown to increase blood pressure in nonpregnant adults with hypertension, but its impact on blood pressure when used for postpartum analgesia in patients with a hypertensive disorder of pregnancy is less clear, particularly for those with severe hypertension.</div></div><div><h3>Objective</h3><div>To evaluate the impact of ibuprofen on postpartum blood pressure outcomes in patients with hypertensive disorders of pregnancy with severe hypertension.</div></div><div><h3>Study design</h3><div><span><span>In this randomized, double-blind trial, we randomly assigned patients with hypertensive disorders of pregnancy with severe hypertension to receive a postpartum analgesic regimen consisting of either ibuprofen 600 mg or </span>acetaminophen 650 mg (control) every 6 hours. The primary outcome was severe hypertension during postpartum hospitalization. Secondary outcomes included other measures of blood pressure control such as </span>antihypertensive<span><span> medication use and average postpartum mean arterial pressure, and outpatient blood pressure as well as patient satisfaction, pain control, and </span>diuresis. A sample size of 132 was needed to detect a 35% difference in severe postpartum hypertension.</span></div></div><div><h3>Results</h3><div>We enrolled 140 participants from January 2017−October 2019. The prevalence of severe hypertension postpartum did not differ between participants receiving ibuprofen (38.6%) vs control (41.4%); the absolute difference was 2.8 percentage points, 95% confidence interval −13.1% to 18.5%, <em>P</em><span>=.73. There was no difference between the ibuprofen and control groups for antihypertensive medication use (35.7% vs 40.0%, </span><em>P</em>=.60) or average postpartum mean arterial pressure (95.7 ± 8.2 vs 95.9 ± 9.5, <em>P</em>=.91, respectively). Measures of outpatient blood pressure, patient satisfaction, diuresis, and pain control were also similar.</div></div><div><h3>Conclusion</h3><div><span>In patients with hypertensive disorders of pregnancy with severe hypertension, use of ibuprofen postpartum did not increase the prevalence of postpartum severe hypertension. Ibuprofen use did not impact other blood pressure outcomes, pain control, or patient satisfaction. These findings support ibuprofen use during the </span>postpartum period in patients with hypertensive disorders of pregnancy.</div></div>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"233 3","pages":"Pages 199.e1-199.e8"},"PeriodicalIF":8.4000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of obstetrics and gynecology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002937825000924","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Ibuprofen has been shown to increase blood pressure in nonpregnant adults with hypertension, but its impact on blood pressure when used for postpartum analgesia in patients with a hypertensive disorder of pregnancy is less clear, particularly for those with severe hypertension.
Objective
To evaluate the impact of ibuprofen on postpartum blood pressure outcomes in patients with hypertensive disorders of pregnancy with severe hypertension.
Study design
In this randomized, double-blind trial, we randomly assigned patients with hypertensive disorders of pregnancy with severe hypertension to receive a postpartum analgesic regimen consisting of either ibuprofen 600 mg or acetaminophen 650 mg (control) every 6 hours. The primary outcome was severe hypertension during postpartum hospitalization. Secondary outcomes included other measures of blood pressure control such as antihypertensive medication use and average postpartum mean arterial pressure, and outpatient blood pressure as well as patient satisfaction, pain control, and diuresis. A sample size of 132 was needed to detect a 35% difference in severe postpartum hypertension.
Results
We enrolled 140 participants from January 2017−October 2019. The prevalence of severe hypertension postpartum did not differ between participants receiving ibuprofen (38.6%) vs control (41.4%); the absolute difference was 2.8 percentage points, 95% confidence interval −13.1% to 18.5%, P=.73. There was no difference between the ibuprofen and control groups for antihypertensive medication use (35.7% vs 40.0%, P=.60) or average postpartum mean arterial pressure (95.7 ± 8.2 vs 95.9 ± 9.5, P=.91, respectively). Measures of outpatient blood pressure, patient satisfaction, diuresis, and pain control were also similar.
Conclusion
In patients with hypertensive disorders of pregnancy with severe hypertension, use of ibuprofen postpartum did not increase the prevalence of postpartum severe hypertension. Ibuprofen use did not impact other blood pressure outcomes, pain control, or patient satisfaction. These findings support ibuprofen use during the postpartum period in patients with hypertensive disorders of pregnancy.
背景:布洛芬已被证明可使未怀孕的高血压成人血压升高,但用于妊娠期高血压疾病患者的产后镇痛对血压的影响尚不清楚,特别是对严重高血压患者。目的:评价布洛芬对妊娠高血压疾病合并重度高血压患者产后血压结局的影响。研究设计:在这项随机双盲试验中,我们随机分配妊娠高血压疾病合并严重高血压的患者,每6小时接受布洛芬600mg或对乙酰氨基酚650mg(对照组)的产后镇痛方案。主要结局为产后住院期间的严重高血压。次要结局包括其他血压控制措施,如抗高血压药物使用和产后平均动脉压,门诊血压以及患者满意度、疼痛控制和利尿。需要132个样本量才能发现35%的产后重度高血压差异。结果:我们从2017年1月至2019年10月招募了140名参与者。服用布洛芬的参与者(38.6%)与对照组(41.4%)产后严重高血压的患病率没有差异;绝对差异为2.8个百分点,95%置信区间为-13.1% ~ 18.5%,p= 0.73。布洛芬组与对照组抗高血压药物使用(35.7% vs 40.0%, p=0.60)或平均产后平均动脉压(95.7+8.2 vs 95.9+9.5, p=0.91)无差异。门诊血压、患者满意度、利尿和疼痛控制的测量也相似。结论:妊娠合并重度高血压的高血压疾病患者,产后使用布洛芬并没有增加产后重度高血压的患病率。布洛芬的使用对其他血压结果、疼痛控制或患者满意度没有影响。这些发现支持妊娠期高血压疾病患者产后使用布洛芬。
期刊介绍:
The American Journal of Obstetrics and Gynecology, known as "The Gray Journal," covers the entire spectrum of Obstetrics and Gynecology. It aims to publish original research (clinical and translational), reviews, opinions, video clips, podcasts, and interviews that contribute to understanding health and disease and have the potential to impact the practice of women's healthcare.
Focus Areas:
Diagnosis, Treatment, Prediction, and Prevention: The journal focuses on research related to the diagnosis, treatment, prediction, and prevention of obstetrical and gynecological disorders.
Biology of Reproduction: AJOG publishes work on the biology of reproduction, including studies on reproductive physiology and mechanisms of obstetrical and gynecological diseases.
Content Types:
Original Research: Clinical and translational research articles.
Reviews: Comprehensive reviews providing insights into various aspects of obstetrics and gynecology.
Opinions: Perspectives and opinions on important topics in the field.
Multimedia Content: Video clips, podcasts, and interviews.
Peer Review Process:
All submissions undergo a rigorous peer review process to ensure quality and relevance to the field of obstetrics and gynecology.